0001348362-20-000006.txt : 20200513
0001348362-20-000006.hdr.sgml : 20200513
20200513123020
ACCESSION NUMBER: 0001348362-20-000006
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20200513
DATE AS OF CHANGE: 20200513
EFFECTIVENESS DATE: 20200513
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lexaria Bioscience Corp.
CENTRAL INDEX KEY: 0001348362
STANDARD INDUSTRIAL CLASSIFICATION: METAL MINING [1000]
IRS NUMBER: 202000871
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0831
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-366822
FILM NUMBER: 20871972
BUSINESS ADDRESS:
STREET 1: 100 - 740 MCCURDY ROAD
CITY: KELOWNA
STATE: A1
ZIP: V1X 2P7
BUSINESS PHONE: 250-765-6424
MAIL ADDRESS:
STREET 1: 100 - 740 MCCURDY ROAD
CITY: KELOWNA
STATE: A1
ZIP: V1X 2P7
FORMER COMPANY:
FORMER CONFORMED NAME: LEXARIA CORP.
DATE OF NAME CHANGE: 20080229
FORMER COMPANY:
FORMER CONFORMED NAME: Lexaria Corp.
DATE OF NAME CHANGE: 20051229
D
1
primary_doc.xml
X0708
D
LIVE
0001348362
Lexaria Bioscience Corp.
100 - 740 MCCURDY ROAD
KELOWNA
A1
BRITISH COLUMBIA, CANADA
V1X 2P7
250-765-6424
NEVADA
LEXARIA CORP.
Lexaria Corp.
Corporation
true
CHRISTOPHER
BUNKA
100 - 740 MCCURDY ROAD
KELOWNA
A1
BRITISH COLUMBIA, CANADA
V1X 2P7
Executive Officer
Director
John
Docherty
100 - 740 MCCURDY ROAD
KELOWNA
A1
BRITISH COLUMBIA, CANADA
V1X 2P7
Executive Officer
Director
Allan
Spissinger
100 - 740 MCCURDY ROAD
KELOWNA
A1
BRITISH COLUMBIA, CANADA
V1X 2P7
Executive Officer
Nicholas
Baxter
100 - 740 MCCURDY ROAD
KELOWNA
A1
BRITISH COLUMBIA, CANADA
V1X 2P7
Director
Ted
McKechnie
100 - 740 MCCURDY ROAD
KELOWNA
A1
BRITISH COLUMBIA, CANADA
V1X 2P7
Director
Brian
Quigley
100 - 740 MCCURDY ROAD
KELOWNA
A1
BRITISH COLUMBIA, CANADA
V1X 2P7
Director
Other
Decline to Disclose
- 06b
false
2020-05-06
false
true
true
true
false
0
Bradley Woods & Co. Ltd.
13660
None
None
805 Third Avenue, 18th Fl
New York
NY
NEW YORK
10022
CA
CALIFORNIA
CT
CONNECTICUT
IL
ILLINOIS
NY
NEW YORK
PA
PENNSYLVANIA
WI
WISCONSIN
true
2039228
2039228
0
true
1
21
151623
0
In addition to the sales commission,the Company issued to the placement agent and its designees Warrants to purchase up to 649,123 shares of common stock and shall, subject to certain exceptions, pay 8% of the proceeds received from warrant exercises.
0
false
Lexaria Bioscience Corp.
/s/ Christopher Bunka
Christopher Bunka
CEO
2020-05-13